Indication assessment · §3

Polycystic ovary syndrome — trial records

Trial records in the Institute's register bearing on polycystic ovary syndrome.

Document identifier: CEI-IN-11/3
Series: Indication assessment
Version: 2.2
Published: 01 Sep 2025
Last reviewed: 01 Sep 2025
Next review: 01 Sep 2027
Identifier: 10.71829/cei.ind.11
Certainty: Not rated
Cycle: 2025 Q3
ICD-11: 5A80.1
Category: Endocrine

§3Trials in this indication

0 trial records in the Institute's register bear on this indication, of which 0 are published trials.

No trial record bears on this indication.

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

D’Hondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, De Spiegeleer B. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis 2014;101:2–30. doi:10.1016/j.jpba.2014.06.012 · PMID 25044089

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Compound Evidence Institute · CEI-IN-11/3 · https://compoundevidence.com/indications/pcos/trials/ · retrieved 30 July 2026